Interesting, page-3766

This is well and truly in the grips of the traders IMO, getting run up and pushed down at their will, while the LT holders such as myself await:

- first enrolment ann
- prelim results ann
- left field Ann (ie development associated with other cancer types)

I would not want to be caught out trading this thing when it goes off.

First enrolment expected 1/3/2021 upon trial registration.

We are obviously past the estimate now, so If we add the biotech/ibx fudge factor of 1-2 months and some news could be around the corner.

Prelim results are expecting to be released as the trial progresses.

This makes for a very exciting set of announcements, that have been years in the making.

And decades of R and D!

I’m hoping to see some successful MRI contrast results especially, this could be huge!

Very exciting times and good luck to all, don’t give those shares away cheaply!

Creep